Biohaven (BHVN) Total Current Liabilities (2021 - 2026)
Biohaven's (BHVN) quarterly Total Current Liabilities came in at $52.1 million in Q1 2026, down 68.25% year-on-year from $164.0 million in Q1 2025, and down 55.08% quarter-over-quarter from $115.9 million in Q4 2025.
Biohaven (BHVN) Total Current Liabilities (2021 - 2026) Analysis & Trends
Biohaven has disclosed Total Current Liabilities across 6 years of filings, most recently posting $52.1 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $52.1 million, down 68.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $52.1 million (down 68.25% YoY), and the FY2025 annual result was $115.9 million, down 24.83% from the prior year.
- Total Current Liabilities came in at $52.1 million for Q1 2026 at Biohaven, down from $115.9 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $164.0 million in Q1 2025 to a low of $28.4 million in Q3 2022.
- The 5-year median for Total Current Liabilities is $113.0 million (2025), against an average of $103.8 million.
- Across the five-year window, Total Current Liabilities surged 178.27% in 2024 and plunged 68.25% in 2026, its largest moves.
- Biohaven's Total Current Liabilities stood at $90.0 million in 2022, then plunged by 38.43% to $55.4 million in 2023, then soared by 178.27% to $154.2 million in 2024, then decreased by 24.83% to $115.9 million in 2025, then sank by 55.08% to $52.1 million in 2026.
- The last three Total Current Liabilities figures came in at $52.1 million (Q1 2026), $115.9 million (Q4 2025), and $113.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | 72.86 Mn |
| 10 | Biohaven | 1.62 Bn | 1.27 Bn | - | 52.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.08 Mn |
| Dec 31, 2025 | 115.93 Mn |
| Sep 30, 2025 | 113.02 Mn |
| Jun 30, 2025 | 124.32 Mn |
| Mar 31, 2025 | 164.03 Mn |
| Dec 31, 2024 | 154.23 Mn |
| Sep 30, 2024 | 152.29 Mn |
| Jun 30, 2024 | 156.21 Mn |
| Mar 31, 2024 | 86.59 Mn |
| Dec 31, 2023 | 55.42 Mn |
| Sep 30, 2023 | 62.18 Mn |
| Jun 30, 2023 | 87.85 Mn |
| Mar 31, 2023 | 114.01 Mn |
| Dec 31, 2022 | 90.02 Mn |
| Sep 30, 2022 | 28.44 Mn |
| Dec 31, 2021 | 41.94 Mn |